Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • IMMUNOLOGICAL CONSEQUENCES AND...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

Bibliographic Details
Main Authors: Hutchinson, J, Riquelme, P, Sawitzki, B, Tomiuk, S, Miqueu, P, Zuhayra, M, Oberg, H, Pascher, A, Luetzen, U, Janssen, U, Broichhausen, C, Renders, L, Thaiss, F, Scheuermann, E, Henze, E, Volk, H, Chatenoud, L, Lechler, R, Wood, K, Kabelitz, D, Schlitt, H, Geissler, E, Faendrich, F
Format: Journal article
Published: 2011
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.
    by: Hutchinson, J, et al.
    Published: (2011)
  • Cutting edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients
    by: Hutchinson, J, et al.
    Published: (2011)
  • In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
    by: Christiane Broichhausen, et al.
    Published: (2014-01-01)
  • Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.
    by: Ondrej Viklicky, et al.
    Published: (2017-01-01)
  • TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
    by: Paloma Riquelme, et al.
    Published: (2018-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs